Skip to content

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation

Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation: a Retrospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05492760
Acronym
era-cryo
Enrollment
600
Registered
2022-08-09
Start date
2022-08-01
Completion date
2024-07-01
Last updated
2022-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The recurrence of atrial fibrillation(AF) after pulmonary vein ablation with cryoballoon is conducted by many factors . The previous studies found larger left atrial and longer AF duration are tied to higher risk of AF recurrence. The characters of ablation procedure is also of critical importance to durable clinical success such as temperature features and time-to-isolation (TTI). The aim of our study is to develop an tool of recurrence risk evaluation with both pre-procedure and procedure factors.

Interventions

DEVICEcryoballoon ablation

Patients with AF will accept cryoballoon ablation.

Sponsors

Shanghai 10th People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Patients with paroxysmal AF and accept cryoballoon ablation.

Exclusion criteria

* left atrium (LA) diameter (anterior-to-posterior)\>55mm on transthoracic echocardiography (TTE) * the presence of thrombus in the LA or left atrial appendage (LAA) on transesophageal echocardiography (TEE) * uncorrected heart failure (NYHA class III or IV), * concomitant moderate or severe valvular heart disease or bioprosthetic valve, * malignancy necessitating chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
the time to atrial fibrillation recurrent1year after the cryoballoon ablationthe time to atrial fibrillation recurrent

Contacts

Primary ContactYawei Xu, doctor
xuyawei@tongji.edu.cn13916698181

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026